Sophos Anti-Virus Nets Deloitte & Touche Fast 50 Award

Sophos Press Release

Sophos, the Oxford-based world leader in corporate anti-virus solutions, has been awarded a prestigious hi-tech award in recognition of its remarkable growth in sales over the last three years.

Sophos, founded in 1980, has been ranked 24th in the Deloitte & Touche Technology Fast 50 South West and Wales region, for its provision of world-leading anti-virus software solutions to major businesses, educational institutes and governmental departments across the globe. 65% of The Financial Times Top 100 Companies currently use Sophos Anti-Virus technology in the UK.

"We're delighted to have been recognised as one of the Fast 50 in the South West because this region is a real hot-bed for IT firms, and so we are in excellent company," said Peter Lammer, managing director for Sophos. "Sophos's success is a direct result of its unique focus on providing corporate networks with the world's most powerful virus protection, as well as first class customer service and technical support. This dedication has enabled Sophos to keep one step ahead of its competitors in this market space throughout the world."

"The Fast 50 programme is a chance for the region's technology businesses to unite and promote the sector," said Mark Mullins, technology partner at the Bristol office of Deloitte & Touche. "Companies like Sophos are putting technology on the map in the South West and Wales, so it is essential that they gain recognition for their success and contribution to the local economy."

More than 100 million users in 150 countries rely on Sophos’ complete security solutions as the best protection against complex threats and data loss. Simple to deploy, manage, and use, Sophos’ award-winning encryption, endpoint security, web, email, mobile and network security solutions are backed by SophosLabs - a global network of threat intelligence centers. Sophos is headquartered in Oxford, U.K., and is publicly traded on the London Stock Exchange under the symbol “SOPH.” More information is available at